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Abstract
Background: Type 2 diabetes mellitus is associated with abnormal markers of  inflammatory cytokines and oxidative stress 
markers. Although, these abnormalities could be modulated with weight reduction; there is limitation in clinical studies that have 
addressed the beneficial effects of  weight reduction in modulating biomarkers of  inflammatory cytokines and oxidative stress 
for obesity associated with type 2 diabetes mellitus. 
Objective: This study was designed to detect the effects of  weight loss on the inflammatory cytokines, oxidative stress markers 
in obese type 2 diabetic patients. 
Material and Methods: Eighty obese patients with type 2 diabetes mellitus, their age ranged from 35-57 years and their body 
mass index ranged from 31-35 kg/m2 were equally assigned into 2 groups:  the weight reduction group received aerobic exercises, 
diet regimen, where as the control group received medical treatment only for 12 weeks. 
Results: The mean values of  body mass index (BMI), tumor necrosis factor–alpha (TNF-α), interleukin-6 (IL-6), C-reactive 
protein (sCRP), conjugated dienes (CD) and malondialdehyde (MDA) were significantly decreased, while the mean values of  
glutathione peroxidase (GPx), superoxide dismutase (SOD) and glutathione (GSH) were significantly increased in patients of  
group (A), while changes were not significant in group (B). Also, there were significant differences between mean levels of  the 
investigated parameters in group (A) and group (B) at the end of  the study. 
Conclusion: Weight loss ameliorates inflammatory cytokines and oxidative stress markers in obese type 2 diabetic patients.
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Introduction
Type 2 diabetes mellitus (T2DM) is considered nowadays 
as a worldwide epidemic and it is responsible for approxi-
mately 90% of  all cases of  diabetes in the world, also it is 
one of  the most important chronic disturbances because 
of  the significant number of  people with diabetes and 
its severe chronic complications, responsible for elevated 
indexes of  morbidity and mortality1. According to World 
Health Organization (WHO), the global forward estima-
tion is that in the year 2030, 366 million people will pres-
ent the disease2.  Patients with T2DM have a two–four 
times increased cardiovascular disease (CVD) risk com-
pared to healthy controls3.  
 
Adipose tissue represents an important source of  cyto-
kines, however excess body fat mass has been associated 
with increased levels of  inflammatory cytokines such as 
TNF-α and IL-64,5. Moreover, a decreased production of  
IL-10 by macrophages and lymphocytes has been associ-
ated with consequent increase of  inflammatory responses 
in patients with Type 2 diabetes mellitus6. Low-grade sys-
temic inflammation is characterized by a two to threefold 
increase in systemic plasma concentrations of  cytokines 
such as tumor necrosis factor (TNF)-α, interleukin (IL)-
6 and C-reactive protein (CRP)7. However, diabetes im-
pacts on the different steps in the pathogenesis of  car-
diovascular diseases (CVD)8-10. T2DM is often associated 
with a "low-grade inflammatory status” accompanied by 
insulin resistance11. Obesity and IR in patients suffering 
from diabetes are associated with a chronic systemic in-
flammation, characterized by an increased expression of  
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inflammatory markers. Multiple stimuli are among the 
most common causes of  myocardial inflammation in car-
diomyopathies in diabetic patients12-14. Systemic inflam-
matory markers are risk factors for the development of  
type 2 diabetes and its macro-vascular complications15. 
Oxidative stress plays a key role in the pathogenesis of  
micro- and macro-vascular diabetic complications. The 
increased oxidative stress in subjects with T2DM is a 
consequence of  several abnormalities, including hyper-
glycemia, IR, inflammation and dyslipidemia16. Oxidative 
stress causes insulin resistance, β-cell dysfunction and late 
diabetic complications17. It was demonstrated that mark-
ers of  inflammation predict or/and are associated with 
T2DM and that inflammation is involved in the patho-
genesis of  atherosclerosis, a common feature of  type 2 
diabetes18.  Free radicals are positively correlated with dia-
betic macro-vascular and micro-vascular complications19. 
 
Obesity is associated with enhanced lipid peroxidation20. 
Oxidative stress is involved in pathological processes such 
as obesity, diabetes and cardiovascular diseases. Obese 
subjects have higher levels of  oxidative stress biomarkers 
compared with control group21. Oxidative stress is known 
as the imbalance between oxidants and antioxidants in fa-
vor of  the oxidants, potentially leading to cellular dam-
age22. Free radicals are reactive oxygen species (ROS) 
having an unpaired electron, which are generated un-
der physiological conditions during aerobic metabolism. 
These free radicals have the potential to trigger chain re-
actions when they react with proteins, lipids and other 
biological molecules, which are fatal to the cell. Under 
normal conditions, the free radicals which are produced 
are scavenged by a repertoire of  enzymatic antioxidants 
like SOD, catalase, glutathione peroxidase (GPx), etc. and 
also by non-enzymatic antioxidants like vitamin C, a-to-
copherol, cerulo-plasmin, GSH etc., thus preventing the 
oxidative stress23,24.  
Caloric restriction (CR), weight loss and exercise amelio-
rate the classic CVD risk factors hypertension and dyslip-
idemia among patients with T2DM25. In addition, weight 
loss and lifestyle interventions decrease plasma IL6 and 
TNFα levels in obese non-diabetic subjects26. Therefore, 
the aim of  this study was to assess the effects of  weight 
loss on the inflammatory cytokines, oxidative stress mark-




The subjects were consecutively recruited among patients 
referred from the outpatient clinics of  the Internal medi-
cine department at King Abdul Aziz University Hospital 
and other Hospitals in Jeddah, Saudi Arabia. Inclusion 
criteria were age (42-55 years), body mass index (BMI) 
30-35 kg/m2 and type 2 diabetes mellitus. We excluded 
patients undergoing any kind of  active treatment that af-
fect the endothelial function, as well as pregnant women, 
those with chronic kidney or liver disease and those with 
congestive heart failure; uncontrollable cardiac arrhyth-
mias, hypertension, musculoskeletal disorders. The sub-
jects were allocated randomly into two study groups: ei-
ther to the lifestyle intervention group (A)  who received 
treadmill aerobic exercise training and diet regimen or to 
the control group (B) who received no exercise training 
and no diet regimen. The original sample consisted of  
236 participants who underwent the eligibility assessment. 
In the enrollment phase, 104 of  them were excluded as 
they didn’t meet inclusion criteria  and 32 refused to par-
ticipate, then the randomization was done. This substudy 
thus included 109 subjects (59 patients in the interven-
tion group and 50 patients in the control group). During 
the follow up,  in the intervention group 6 patients dis-
continued intervention (3 patients disliked the diet regi-
men, 2 patients had work related schedule problems and 
1 patient discontinued due to unknown reasons) and in 
the control group 3 patients discontinued intervention 
(2 patients had work related schedule problems and 1 
patient discontinued due to unknown reason). In addi-
tion, 5 patients in the intervention group and 4 patients 
in the control group were excluded from the analysis due 
to insufficient blood sample. This study was approved by 
the Ethical Committee for Scientific Research, Faculty of  
Applied Medical Sciences, King Abdulaziz University. All 
participants provided written informed consent.
 
Measurements
In all subjects, clinical and anthropometric data was col-
lected at the time of  enrollment. Clinical evaluations and 
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laboratory analysis were performed by independent as-
sessors who were blinded to group assignment and not 
involved in the routine treatment of  the patients. Body 
mass index (BMI) was calculated on the basis of  weight 
(kilograms) and height (meters), and subjects were clas-
sified as normal weight (BMI 18.5–24.9 kg/m2), over-
weight (BMI 25–29.9 kg/m2), and obese (BMI ≥30 kg/
m2). In addition, between 07:30 and 09:00, after an over-
night fast of  12 h fasting blood sample was drawn. The 
plasma lipid profile (total cholesterol, total triglycerides, 
high-density lipoprotein (HDL), and low-density lipo-
protein (LDL), plasma glucose concentration and insulin 
were determined (Roche Diagnostics GmbH, Mannheim, 
Germany) using commercially available assay kits. Insu-
lin resistance was assessed by homeostasis model assess-
ment (HOMA-IR). HOMA-IR = fasting blood glucose 
(mmol/l) - fasting insulin (mIU/ml)/22.527.
A. Measurement of  oxidative stress markers and an-
ti-oxidant status: 
For all participants serum (from 10 ml blood in plain 
vial) and plasma (from 5 ml blood in EDTA vial) were 
separated from the sample within 30 min of  collection 
and stored in pyrogen free polypropylene cryo-tubes at 
(-80ºC) until analysis. Assessment of  lipid markers for 
peroxidation such as malondialdehyde (MDA) and con-
jugated dienes (CD) were determined according to Buege 
and Aust method.28. However, Anti-oxidant status, gluta-
thione (GSH) was determined by the method of  Beutler 
and colleagues29, on the other hand, glutathione peroxi-
dase (GPx) and superoxide dismutase (SOD) were mea-
sured by the method of  Nishikimi and colleagues30.
B. Measurement of  inflammatory cytokines: 
Venous blood samples after a 12-hours fasting were cen-
trifuged at 4 °C (1000 X g for 10 min). Interleukin-6 (IL-
6) levels were analyzed by “Immulite 2000” immune-as-
say analyzer (Siemens Healthcare Diagnostics, Deerfield, 
USA). However, (TNF-α), (sCRP) and interleukin-8 (IL-
8) levels were measured by ELISA kits (R&D, USA) using 
ELISA technique (ELX 808; Bio-Tek Instruments, USA).
All measurements of  BMI, IL-6, TNF-α, sCRP, MDA, 
CD, CPX, GSH and SOD were taken before the start of  
the study (pre-test) and after three months at the end of  
the study (post-test).
Procedures
We hypothesized that weight reducing program included 
treadmill aerobic exercise and diet regimen for 12 weeks 
would result in modulation in inflammatory cytokines 
and oxidative stress markers in obese patients with type 
2 diabetes mellitus. As such, we randomized our subjects 
into either a training group(A) or a control group (B). 
As All patients were divided randomly into the following 
groups:
1. The training group (Group A): 
Patients were submitted to the aerobic exercise training 
to complete a 12-week aerobic exercise-training program 
on a treadmill aerobic exercise (Enraf  Nonium, Model 
display panel Standard, NR 1475.801, Holland). Each ses-
sion of  physical exercise was divided in: 5 min of  warm 
up, with stretching exercises and circling of  members and 
body; 30 min of  aerobic exercise divided into row ergom-
eter (15 min) and bicycle ergometer (15 min).; and 5 min 
of  cold down at the end, with stretching, flexibility and 
relaxation exercises, consisting of  five sessions per week. 
The training program was performed at 70% of  the indi-
vidual age-predicted HRmax according to Tanaka et al., 
31. In addition, a dietician performed an interview-based 
food survey for all participants of  group (A) for detec-
tion of  feeding habits, abnormal dietary behavior and to 
prescribe the balanced low calorie that provide 1200 Kilo 
calories/day for 12 weeks.
2. The control group (Group B):  
Patients maintained their ordinary life style and received 
no exercise or diet regimen training.
Statistical analysis
All results are presented as means ± SD. The mean values 
of  the investigated parameters obtained before and after 
the study. Independent "t" test was used for the compari-
son between the two groups (P<0.05).
Results
The two groups considered homogeneous regarding the 
baseline clinical variables (Table 1). 
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The mean values of  body mass index (BMI), (TNF-α), 
(IL-6), (sCRP), conjugated dienes (CD) and malondialde-
hyde (MDA) were significantly decreased, while the mean 
values of  glutathione peroxidase (GPx), superoxide dis-
mutase (SOD) and glutathione (GSH) were significantly 
increased in patients of  group (A)  (Table 2), while chang-
es were not significant in group (B) (Table 3). 
Also, there were significant differences between mean 
levels of  the investigated parameters in group (A) and 
group (B) at the end of  the study (Table 4).
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Age (year) 48.36 ± 5.12 47.17 ± 5.63 P >0.05 
Gender ( Male/Female) 23/17 21/19 P >0.05 
Weight (kg) 88.92 ± 5.76 90.11± 6.24 P >0.05 
Height (cm) 169.17 ± 8.22 171.37 ± 7.81 P >0.05 
Waist-hip ratio 0.86 ± 0.05 0.88 ± 0.07 P >0.05 
BMI (kg/m2) 31.85 ± 3.46 32.24 ± 3.62 P >0.05 
SBP ( mm Hg) 123.41 ± 7.23 125.16 ± 8.27 P >0.05 
DBP (mm Hg) 82.65 ± 6.81 84.12 ± 5.78 P >0.05 
TC  (mg/dl) 193.14 ± 9.55 195.26 ±10.17 P >0.05 
LDL-c  (mg/dl) 132.53 ± 7.11 135.16 ± 8.26 P >0.05 
TG   (mg/dl) 154.05 ± 9.25 156.49 ±8.77 P >0.05 
HDL-c  (mg/dl) 35.21 ± 2.15 33.85 ±2.36 P >0.05 
HOMA-IR 4.82 ± 1.67 4.96 ± 1.44 P >0.05 
HbA1C (%)  7.66±1.58 7.83±1.73 P >0.05 
Diabetes duration (year)  11.16 ± 2.11 12.24 ± 1.88 P >0.05 
 
BMI: Body mass index; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; TC: Total cholesterol; LDL-c: Low-
density lipoprotein cholesterol; TG: Triglyceride; HDL-c: High-density lipoprotein cholesterol; HOMA-IR: Homeostasis 
Model Assessment-Insulin Resistance Index; HbA1C: Glycosylated hemoglobin; * Significant level (p<0.05). 
BMI: Body mass index; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; TC: Total 
cholesterol; LDL-c: Low-density lipoprotein cholesterol; TG: Triglyceride; HDL-c: High-density 
lipoprotein cholesterol; HOMA-IR: Homeostasis Model Assessment-Insulin Resistance Index; 
HbA1C: Glycosylated hemoglobin; * Significant level (p<0.05). 
Discussion Type 2 diabetes mellitus is the most prevalent metabolic 
disease in the world32, which is related to vascular prob-
Table (3): Mean value and significance of different variables such as (IL-6, TNF-
α, sCRP, ICAM-1, VCAM-1and PAI-1: Ac) in-group (B) before and at the end of 
the study. 
 
  Mean +SD Significance 
Before After 
BMI (kg/m2) 32.24 ± 3.62 32.41 ± 3.68 P >0.05 
TNF- α (pg/mL) 12.13 ± 2.54 12.26 ± 2.56 P >0.05 
IL-6 (pg/mL) 5.91 ± 1.43 5.95 ± 1.61 P >0.05 
sCRP( mg/L) 4.43 ±  1.29 4.51±  1.32 P >0.05 
CD (mmol/L) 25.17 ± 4.76 25.68 ± 4.79 P >0.05 
MDA (mmol/L) 25.36 ± 5.12 25.72 ± 5.26 P >0.05 
GPx (units/gHb) 20.98 ± 3.75 20.63 ± 3.41 P >0.05 
SOD (units/mL) 43.16 ± 5.14 42.77 ± 4.96 P >0.05 
GSH (mmol/gHb) 2091.30 ± 162.72 2064.83± 151.41 P >0.05 
BMI: Body mass index; TNF- α: tumor necrosis factor – alpha; IL-6: Interleukin-6; sCRP: C- reactive 
protein; CD: conjugated dienes; MDA: Malondialdehyde; GPx: Glutathione peroxidase; SOD: Superoxide 
dismutase; GSH: Glutathione. 
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Table (2): Mean value and significance of different variables such as (IL-6, TNF-
α, sCRP, ICAM-1, VCAM-1and PAI-1: Ac) in-group (A) before and at the end of 
the study. 
 
  Mean ±SD Significance 
Before After 
BMI (kg/m2) 31.85 ± 3.46 25.47 ± 2.65* P<0.05 
TNF- α (pg/mL) 11.94 ± 2.63 8.23 ± 2.48* P<0.05 
IL-6 (pg/mL) 5.87 ± 1.34 3.41 ± 1.25* P<0.05 
sCRP ( mg/L) 4.26 ±  1.22 2.12 ± 0.91* P<0.05 
CD (mmol/L) 24.66 ± 5.14 18.72 ± 4.15* P<0.05 
MDA (mmol/L) 25.27 ± 5.26 19.13 ± 4.32* P<0.05 
GPx (units/gHb) 21.33 ± 4.11 26.22 ± 3.73* P<0.05 
SOD (units/mL) 43.51 ± 5.57 52.87 ± 6.28* P<0.05 
GSH (mmol/gHb) 2134.11 ± 173.18 2588.25 ± 191.17* P<0.05 
BMI: Body mass index; TNF- α: tumor necrosis factor – alpha; IL-6: Interleukin-6; sCRP: C- reactive 
protein; CD: conjugated dienes; MDA: Malondialdehyde; GPx: Glutathione peroxidase; SOD: Superoxide 
dismutase; GSH: Glutathione; * Significant level (p<0.05). 
BMI: Body mass index; TNF- α: tumor necrosis factor – alpha; IL-6: Interleukin-6; sCRP: C- 
reactive protein; CD: conjugated dienes; MDA: Malondialdehyde; GPx: Glutathione peroxidase; 
SOD: Superoxide dismutase; GSH: Glutathione. 
lems33,34. The American Heart Association recommended 
weight loss to reduce the severity of  cardiovascular risk 
factors in overweight and obese patients35. The main find-
ing of  the present study was that weight reducing pro-
gram ameliorated inflammatory cytokines (TNF-α, IL-6, 
sCRP) and markers of  oxidative and anti-oxidative stress 
(MDA, CD, CPX, GSH and SOD) in obese patients with 
type 2 diabetes mellitus  as a result of  weight loss, these 
results are in line with many previous studies.
 
The effect of  dietary interventions on sCRP levels has 
been studied in obese non-diabetic subjects. Weight loss 
was clearly associated with a decrease in sCRP in these 
subjects and related to the amount of  weight loss36. In 
obese non-diabetic patients, diet, exercise or combined 
interventions have controversial effects on plasma IL-6 
and TNF-α level37-43. Sheu and colleagues reported that 
5% of  body weight loss obtained after 12 weeks of  ca-
loric restriction and exercises resulted in significant re-
duction in  TNF-α and IL-6 of  obese women44. Lang and 
colleagues established that a weight-reducing program 
had anti-atherogenic and inflammatory effects in their 
study on three obese men and eleven obese women for 
eight weeks45. Choo and colleagues proved that weight-
reducing program in the form of  diet regimen for three 
months followed by diet regimen added to exercise inter-
vention for nine months had a remarkable reduction in 
the risk of  cardio-metabolic and subclinical atheroscle-
rosis46. Madsen and colleagues stated that inflammatory 
markers were reduced significantly if  body weight was 
reduced by 10% in obese subjects47. Esposito e al. sug-
gested that weight-reducing program for 2 years signifi-
cantly reduced C-reactive protein48. In addition, Nicklas 
and colleagues stated that 12 months life style modifica-
tion program significantly reduced TNF-α level in obese 
individuals49. Reductions in pro-inflammatory cytokines 
concentrations after weight loss is explained by reduction 
in fat mass50.
 
Concerning the markers of  oxidative and anti-oxidative 
stress, the observation in this study indicated a significant 
reduction in MDA & CD and increased in CPX, GSH 
and SOD as a result of  weight loss at the end of  the 
study. Nevertheless, the current data is in line with one 
previous study by Roberts et al. Proved that after three 
weeks of  combination between diet and exercise there 
was a significant reduction in BMI, lipid profile, fasting 
blood sugar, sCRP and insulin homeostasis which ame-
liorates oxidative stress, inflammation and monocytes-
endothelial interaction among diabetic patients51.
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Table (4): Mean value and significance of (IL-6, TNF-α, sCRP, ICAM-1, VCAM-1 
and PAI-1: Ac) in group (A) and group (B) at the end of the study. 
 
  Mean +SD Significance 
Group (A) Group (B) 
BMI (kg/m2) 25.47 ± 2.65* 32.41 ± 3.68 P<0.05 
TNF- α (pg/mL) 8.23 ± 2.48* 12.26 ± 2.56 P<0.05 
IL-6 (pg/mL) 3.41 ± 1.25* 5.95 ± 1.61 P<0.05 
sCRP( mg/L) 2.12 ± 0.91* 4.51±  1.32 P<0.05 
CD (mmol/L) 18.72 ± 4.15* 25.68 ± 4.79 P<0.05 
MDA (mmol/L) *19.13 ± 4.32* 25.72 ± 5.26 P<0.05 
   GPx (units/gHb) 26.22 ± 3.93* 20.63 ± 3.41 P<0.05 
SOD (units/mL) 52.87 ± 6.28* 42.77 ± 4.96 P<0.05 
GSH (mmol/gHb) 2588.25 ± 191.17* 2064.83 ± 151.41 P<0.05 
BMI: Body mass index; TNF- α: tumor necrosis factor – alpha; IL-6: Interleukin-6; sCRP: C- reactive 
protein; CD: conjugated dienes; MDA: Malondialdehyde; GPx: Glutathione peroxidase; SOD: Superoxide 
dismutase; GSH: Glutathione; * Significant level (p<0.05). 
The possible mechanism for modulation of  the oxidative 
stress markers induced by weight reduction could be due 
to reverse the mechanism by which obesity produces oxi-
dative stress. The first of  these is the mitochondrial and 
peroxisomal oxidation of  fatty acids, which can produce 
ROS in oxidation reactions, while another mechanism is 
over-consumption of  oxygen, which generates free radi-
cals in the mitochondrial respiratory chain that is found 
coupled with oxidative phosphorylation in mitochondria. 
Lipid-rich diets are also capable of  generating ROS be-
cause they can alter oxygen metabolism52. So that upon 
reduction of  adipose tissue, the activity of  antioxidant 
enzymes such as SOD, catalase (CAT), and GPx, was 
found to be significantly increased.
 
Conclusion
Weight loss ameliorates inflammatory cytokines and oxi-
dative stress markers in obese type 2 diabetic patients.
Acknowledgment
This project was funded by the Deanship of  Scientific 
Research (DSR), King Abdulaziz University, Jeddah, un-
der grant no. (142/4/D1436). The authors, therefore, ac-
knowledge with thanks DSR technical and financial sup-
port.
References
1. Cruz NG, Sousa LP, Sousa MO, Pietrani NT, Fernandes 
AP, Gomes KB. The linkage between inflammation and 
Type 2 diabetes mellitus. Diabetes Res Clin Pract 2013; 99 
(2):85-92.
2. Li R, Lu W, Jiang QW, Li YY, Zhao GM, Shi L, et al. In-
creasing prevalence of  Type 2 diabetes in Chinese adults 
in Shanghai. Diabetes Care 2012;35(5):1028–30. PubMed
3. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabe-
tes, other risk factors, and 12-yr cardiovascular mortality 
for men screened in the Multiple Risk Factor Interven-
tion Trial. Diabetes Care 1993; 16: 434 – 444. PubMed
4. Carvalho MHC, Colac¸o AL, Fortes ZB. Citocinas 
Disfunc¸a˜o Endotelial e Resisteˆncia a` Insulina. Arq 
Bras Endocrinol Metab 2006:50(2):304–12.
5. DandonaP, Aljada A, Bandyopadhyay A. Inflammation: 
the link between insulin resistance, obesity and diabetes. 
Trends Immunol 2004; 25(1):4–7. PubMed
6. Exel EV, Gussekloo J, Craen AJM, Frolich M, Wiel AB, 
Westendorp RGJ. Low production capacity of  interleu-
kin-10 associates with the metabolic syndrome and Type 
2 diabetes. Diabetes 2002;51:1088– 92. PubMed
7. Petersen AM, Pedersen BK. The anti-inflammatory 
effect of  exercise. J Applied Physiol 2005;98:1154–62. 
PubMed
8. Dobrin JS, Lebeche D. Diabetic cardiomyopathy: sig-
naling defects and therapeutic approaches. Expert Rev 
Cardiovasc Ther 2010;8: 373–391.
9.  Opie LH, Yellon DM, Gersh BJ. Controversies in the 
cardiovascular management of  type 2 diabetes. Heart 
2011;97: 6–14. PubMed
10. Singh S, Dhingra S, Ramdath DD, Vasdev S, Gill V, 
Singal PK. Risk factors preceding type 2 diabetes and car-
diomyopathy. J Cardiovasc Transl Res 2010; 3: 580–596.
11. Vaarala O, Yki-Jarvinen H. Diabetes: should we treat 
infection or inflammation to prevent T2DM? Nature Re-
views. Endocrinology 2012; 8: 323–325. PubMed
12. Herder C, Karakas M, Koenig W.  Biomarkers for the 
prediction of  type 2 diabetes and cardiovascular disease. 
Clin Pharmacol Ther 2011; 90: 52– 66. PubMed
13. Marchant DJ, Boyd JH, Lin DC, Granville DJ, Gar-
maroudi FS, McManus BM. Inflammation in myocardial 
diseases. Circ Res 2012; 110: 126–144. PubMed
14. Taube A, Schlich R, Sell H, Eckardt K, Eckel J . In-
flammation and metabolic dysfunction: links to cardio-
vascular diseases. Am J Physiol Heart Circ Physiol 2012; 302: 
H2148–H2165.
15. Esser N, Legrand-Poels S, Piette J, Scheen AJ, Paquot 
N. Inflammation as a link between obesity, metabolic syn-
drome and type 2 diabetes. Diabetes Res Clin Pract 2014; 
105(2):141-50.
16. Paoletti R, Bolego C, Poli A, Cignarella A. Metabolic 
syndrome, inflammation and atherosclerosis. Vasc Health 
Risk Manag 2006; 2:145–152.
17. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. 
Are oxidative stress activated signaling pathways media-
tors of  insulin resistance and beta-cell dysfunction?. Dia-
betes 2003; 52: 1–8.
18. Pickup  JC. Inflammation and activated innate immu-
nity in the pathogenesis of  type 2 diabetes, Diabetes Care 
2004; 27: 813–823. PubMed
19. Chaudhuri A, Umpierrez GE. Oxidative stress and 
inflammation in hyperglycemic crises and resolution with 
insulin: implications for the acute and chronic complica-
tions of  hyperglycemia. Journal of  Diabetes and its Complica-
tions 2012;26: 257–258.
African Health Sciences Vol 16 Issue 3, September 2016731
20. Murdolo G, Piroddi M, Luchetti F, Tortoioli C, Cano-
nico B, Zerbinati C, et al.  Oxidative stress and lipid per-
oxidation by-products at the crossroad between adipose 
organ dysregulation and obesity-linked insulin resistance. 
Biochimie 2012;95(3):585–94. PubMed
21.  Keaney Jr , Larson MG, Vasan RS, Wilson PW, Lipin-
ska I, Corey D, et al. Obesity and systemic oxidative stress: 
clinical correlates of  oxidative stress in the Framingham 
study. Arterioscler Thromb Vasc Biol 2003; 23:434–9.
22. Iuliano L. Pathways of  cholesterol oxidation via non-
enzymatic mechanisms. Chem Phys Lipids 2011; 164:457–
68. PubMed
23. Mataix J, Quiles JL, Heurtas JR, Battino M, Manas M. 
Tissue specific interactions of  exercise, dietary fatty acids, 
and vitamin E in lipid peroxidation. Free Radic  Biol Med 
1998; 24:511–21. PubMed
24. Saad EA. Curative and protective effects of  L-argi-
nine on carbon tetrachloride- induced hepatotoxicity in 
mice. Biochem Biophys Res Commun 2012; 423: 147–51.
25. Roberts CK, Barnard RJ. Effects of  exercise and diet 
on chronic disease. J Appl Physiol 2005; 98: 3–30. PubMed
26. Herder C, Peltonen M, Koenig W, Sutfels K, Lind-
strom J, Martin S, Ilanne-Parikka P, Eriksson JG, Aunola 
S, Keinanen-Kiukaanniemi S, Valle TT, Uusitupa M, Kolb 
H, Tuomilehto J. Anti-inflammatory effect of  lifestyle 
changes in the Finnish Diabetes Prevention Study. Diabe-
tologia 2009; 52: 433–442.
27. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, 
Treacher DF, Turner RC. Homeostasis model assess-
ment: insulin resistance and beta cell function from plas-
ma FBS and insulin concentrations in man. Diabetologia 
1985; 28:412–9. PubMed
28. Buege JA, Aust SD. Microsomal lipid peroxidation. 
Methods Enzymol 1978; 52:302–310. PubMed
29. Beutler E, Duron O, Kelly BM. Improved method for 
the determination of  blood glutathione. J Lab Clin Med 
1963;61:882–888. PubMed
30. Nishikimi M, Appaji Rao N, Yagi K. The occurrence 
of  superoxide anion in the reaction of  reduced phenazine 
methosulfate and molecular oxygen. Biochem Biophys Res 
Commun 1972; 46:849–854.
31. Tanaka H, Monahan K, Seals D. Age-predicted maxi-
mal heart rate revisited. J Am Coll Cardiol 2001; 37: 153–
156. PubMed
32. Donath MY, Shoelson SE. Type 2 diabetes as an in-
flammatory disease. Nat Rev Immunol 2011; 11:98–107. 
PubMed
33. Avogaro A, Albiero M, Menegazzo L, de Kreutzen-
berg S, Fadini GP. Endothelial dysfunction in diabetes: 
the role of  reparatory mechanisms. Diabetes Care 2011; 34 
(Suppl 2): S285–290.
34. Ding H, Triggle CR . Endothelial dysfunction in dia-
betes: multiple targets for treatment. Pflugers Arch  2010; 
459: 977–994.
35. Klein S, Burke LE, Bray GA. Clinical implications 
of  obesity with specific focus on cardiovascular disease: 
a statement for professionals from the American Heart 
Association Council on Nutrition, Physical Activity, and 
Metabolism: Endorsed by the American College of  Car-
diology Foundation. Circulation 2004;110:2952-2967  .
36. Selvin E, Paynter NP, Erlinger TP. The effect of  
weight loss on C-reactive protein: a systematic review. 
Arch Intern Med 2007; 167: 31–39. PubMed
37. Herder C, Peltonen M, Koenig W, Sutfels K, Lind-
strom J, Martin S, Ilanne- Parikka P, Eriksson JG, Aunola 
S, Keinanen-Kiukaanniemi S, Valle TT, Uusitupa M, Kolb 
H, Tuomilehto J. Anti-inflammatory effect of  lifestyle 
changes in the Finnish Diabetes Prevention Study. Diabe-
tologia 2009;52: 433–442. PubMed
38. You T, Berman DM, Ryan AS, Nicklas BJ. Effects 
of  hypocaloric diet and exercise training on inflammation 
and adipocyte lipolysis in obese postmenopausal women. 
J Clin Endocrinol Metab 2004; 89: 1739–1746.
39. Ziccardi P, Nappo F, Giugliano G, Esposito K, 
Marfella R, Cioffi M, D’Andrea F, Molinari AM, Giug-
liano D. Reduction of  inflammatory cytokine concentra-
tions and improvement of  endothelial functions in obese 
women after weight loss over one year. Circulation 2002; 
105: 804–809. PubMed
40. Wegge J, Roberts CK, Ngo TH, Barnard RJ. Effect 
of  diet and exercise intervention on inflammatory and 
adhesion molecules in postmenopausal women on hor-
mone replacement therapy and at risk for coronary artery 
disease. Metabolism 2004; 53: 377–381. PubMed
41. Bruun JM, Helge JW, Richelsen B, Stallknecht B.. Diet 
and exercise reduce low-grade inflammation and mac-
rophage infiltration in adipose tissue but not in skeletal 
muscle in severely obese subjects. Am J Physiol Endocrinol 
Metab 2006; 290:E961–E967.
42. Christiansen T, Paulsen SK, Bruun JM, Pedersen 
SB, Richelsen B. Exercise training versus diet-induced 
weight-loss on metabolic risk factors and inflammatory 
markers in obese subjects: a 12-week randomized inter-
vention study. Am J Physiol Endocrinol Metab 2010; 298: 
E824–E831.
African Health Sciences Vol 16 Issue 3, September 2016 732
43. Klimcakova E, Polak J, Moro C, Hejnova J, Majercik 
M, Viguerie N, Berlan M, Langin D, Stich V. Dynamic 
strength training improves insulin sensitivity without al-
tering plasma levels and gene expression of  Adipokines 
in subcutaneous adipose tissue in obese men. J. Clin. En-
docrinol. Metab 2006; 91: 5107– 5112. PubMed
44. Sheu WH, Chang TM, Lee WJ, Ou HC, Wu CM, Tseng 
LN, Lang HF, Wu CS, Wan CJ, Lee IT. Effect of  weight 
loss on pro-inflammatory state of  mononuclear cells in 
obese women. Obesity (Silver Spring) 2008,16(5):1033-8. 
PubMed
45. Lang HF, Chou CY, Sheu WH, Lin JY. Weight loss 
increased serum adiponectin but decreased lipid levels in 
obese subjects whose body mass index was lower than 30 
kg/m². Nutr Res 2011; 31(5):378-86. PubMed
46. Choo J, Lee J, Cho JH, Burke LE, Sekikawa A, Jae 
SY. Effects of  weight management by exercise modes on 
markers of  subclinical atherosclerosis and cardiometa-
bolic profile among women with abdominal obesity: a 
randomized controlled trial. BMC Cardiovasc Disord 2014; 
10: 14:82.
47. Madsen EL, Rissanen A, Bruun JM. Weight loss larger 
than 10% is needed for general improvement of  levels of  
circulating adiponectin and markers of  inflammation in 
obese subjects: a 3-year weight loss study. Eur J Endocrinol 
2008;158(2):179–187. PubMed
48. Ryan AS, Nicklas BJ, Berman DM, Elahi D. Adipo-
nectin levels do not change with moderate dietary in-
duced weight loss and exercise in obese postmenopausal 
women. Int J Obes Relat Metab Disord 2003; 27:1066-71.
49. Nicklas BJ, You T, Pahor M. Behavioral treatments for 
chronic systemic inflammation: effects of  dietary weight 
loss and exercise training. CMAJ 2005; 172:1199-209.
50. Marfella R, Esposito K, Siniscalchi M. Effect of  
weight loss on cardiac synchronization and proinflamma-
tory cytokines in premenopausal obese women. Diabetes 
Care 2004; 27,47–52. PubMed
51. Roberts CK, Won D, Pruthi S, Lin SS, Barnard RJ. 
Effect of  a diet and exercise intervention on oxidative 
stress, inflammation and monocyte adhesion in diabetic 
men. Diabetes Res Clin Pract 2006;73(3):249-59.
52. Ferna´ndez-Sa´nchez A, Madrigal-Santilla´n E, Bau-
tista M, Esquivel-Soto J, Mor-  ales-Gonza´ lez A, Esquiv-
el-Chirino C, et al. Inflammation, oxidative stress, and 
544 obesity. Int J Mol Sci 2011; 12(5),:3117–32. PubMed
 
African Health Sciences Vol 16 Issue 3, September 2016733
